Author:
Hajimirzaei Pooya,Eyni Hossein,Razmgir Maryam,Abolfazli Sajad,Pirzadeh Simin,Ahmadi Tabatabaei Faeze Sadat,Vasigh Ayda,Yazdanian Nafiseh,Ramezani Fatemeh,Janzadeh Atousa,Butler Alexandra E.,Sahebkar Amirhossein
Publisher
Springer Science and Business Media LLC
Reference132 articles.
1. Abd Allah ES, Gomaa AM (2015) Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1. Appl Physiol Nutr Metab 40(10):1061–1067
2. Abdolahi M, Jafarieh A, Sarraf P, Sedighiyan M, Yousefi A, Tafakhori A et al (2019) The neuromodulatory effects of ω-3 fatty acids and nano-curcumin on the COX-2/iNOS network in migraines: a clinical trial study from gene expression to clinical symptoms. Endoc Metab Immune Disord Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 19(6):874–84
3. Amalraj A, Varma K, Jacob J, Divya C, Kunnumakkara AB, Stohs SJ et al (2017) A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food 20(10):1022–1030
4. Ambegaokar SS, Wu L, Alamshahi K, Lau J, Jazayeri L, Chan S et al (2003) Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuroendocrinol Lett 24(6):469
5. Amirchaghmaghi M, Pakfetrat A, Delavarian Z, Ghalavani H, Ghazi A (2016) Evaluation of the efficacy of curcumin in the treatment of oral lichen planus: a randomized controlled trial. J Clin Diagn Res JCDR 10(5):ZC134